Kanwar, Amrinder JSawatkar, Gitesh UVinay, KeshavamurthyHashimoto, Takashi2012-09-072012-09-072012-09Kanwar Amrinder J, Sawatkar Gitesh U, Vinay Keshavamurthy, Hashimoto Takashi. Childhood pemphigus vulgaris successfully treated with rituximab. Indian Journal of Dermatology, Venereology and Leprology. 2012 Sept-Oct; 78(5): 632-634.http://imsear.searo.who.int/handle/123456789/141179Pemphigus is a potentially fatal autoimmune epidermal bullous disorder. Rituximab is a novel therapy for the treatment of refractory pemphigus. However, there is limited clinical data on safety and efficacy of rituximab in pediatric age group. Herein, we report an 11-year-old boy of childhood pemphigus vulgaris who failed to respond to dexamethasone pulse therapy and was subsequently treated with rituximab and achieved complete remission.enAutoimmune bullous diseaseschildhood pemphigus vulgarisrituximabArticle